{"lastClose": 10.350000381469727, "len": 646, "date": "2023-02-15", "alpha_1": -0.11760297520165575, "beta_1": 1.5743339176807445, "drawup_1": 1.513959286579007, "natr_1": 12.733742150830436, "sup_1": -0.1504025734032804, "res_1": 0.236875952253752, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 47.19001243434875, "adx_1": 20.09211520827983, "drawdown_1": -0.5517633590080399, "stratHoldSharpe_1": -0.2723423219904782, "stratHoldAlpha_1": 250.80188767613018, "stratHoldDrawdown_1": -0.4965870231072359, "alpha_3mo": -0.12088188442950809, "beta_3mo": 1.7040191188103544, "drawup_3mo": 0.3448276562466299, "natr_3mo": 12.733742150830436, "sup_3mo": -0.12592591637041337, "res_3mo": 0.0776167394069823, "bullPattern_3mo": [], "bearPattern_3mo": ["SHORTLINE"], "rsi_3mo": 35.955055147790446, "adx_3mo": 34.37407860056484, "drawdown_3mo": -0.2415384879479041, "stratHoldSharpe_3mo": -1.2455364744344157, "stratHoldAlpha_3mo": 250.2948341202751, "stratHoldDrawdown_3mo": -0.21738463915311368, "Sector": "Health Care", "IPO Year": 2020.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Market Cap": 485494716, "Name": "Nurix Therapeutics Inc. Common stock", "Country": "United States", "alpha%_1": 0.461280356417424, "beta%_1": 0.8734160795137288, "drawup%_1": 0.9962739100644689, "natr%_1": 0.999956418044749, "drawdown%_1": 0.2043579515883211, "stratHoldSharpe%_1": 0.2810473520478989, "stratHoldAlpha%_1": 0.16878391018453615, "stratHoldDrawdown%_1": 0.21445116739501957, "alpha%_3mo": 0.22904579275820464, "beta%_3mo": 0.9074488009807908, "drawup%_3mo": 0.6941642586973128, "natr%_3mo": 0.9999398835563081, "drawdown%_3mo": 0.11475051298069933, "stratHoldSharpe%_3mo": 0.06758516086239297, "stratHoldAlpha%_3mo": 0.028689566433560017, "stratHoldDrawdown%_3mo": 0.11752449127019715}